KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Elevance Health (ELV) Short-Term Debt repayments (2016 - 2025)

Elevance Health (ELV) has disclosed Short-Term Debt repayments for 15 consecutive years, with $545.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-Term Debt repayments rose 808.33% to $545.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 1174.07% increase, with the full-year FY2025 number at $1.7 billion, up 1174.07% from a year prior.
  • Short-Term Debt repayments was $545.0 million for Q4 2025 at Elevance Health, down from $1.2 billion in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $1.2 billion in Q3 2025 to a low of -$110.0 million in Q2 2025.
  • A 5-year average of $375.6 million and a median of $175.0 million in 2023 define the central range for Short-Term Debt repayments.
  • Peak YoY movement for Short-Term Debt repayments: tumbled 71.43% in 2022, then surged 1460.0% in 2025.
  • Elevance Health's Short-Term Debt repayments stood at $1.0 billion in 2021, then crashed by 71.43% to $300.0 million in 2022, then crashed by 41.67% to $175.0 million in 2023, then crashed by 65.71% to $60.0 million in 2024, then skyrocketed by 808.33% to $545.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Short-Term Debt repayments are $545.0 million (Q4 2025), $1.2 billion (Q3 2025), and -$110.0 million (Q2 2025).